Related Experiment Video
Updated: Jun 8, 2026
15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease
Bahareh Behrouz1, Carles Vilariño-Güell, Michael G Heckman
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA. bahareh.lee@gmail.com
Neuroscience Letters
|October 5, 2010
Summary
Genetic variants in the mitochondrial translation initiation factor 3 (MTIF3) gene may influence Parkinson's disease (PD) risk. This study found an association between a specific MTIF3 polymorphism and PD in Caucasian populations.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mitochondrial dysfunction is implicated in Parkinson's disease (PD) pathogenesis.
- Genetic factors influencing mitochondrial function are linked to PD susceptibility.
- A prior study associated a single nucleotide polymorphism in the MTIF3 gene with PD risk.
Purpose of the Study:
- To investigate the association between the rs7669 polymorphism in the MTIF3 gene and sporadic Parkinson's disease.
- To determine if MTIF3 gene variations contribute to PD etiology.
Main Methods:
- Case-control study design.
- Analysis of the rs7669 polymorphism in the MTIF3 gene.
- Genotyping was performed on three independent Caucasian cohorts (total n=2434).
Main Results:
- A significant association between the CC genotype of rs7669 and PD risk was observed in the largest Norwegian cohort (n=1650).
- Similar, though non-significant, trends were noted in Irish and US cohorts.
- Combined analysis of all cohorts revealed a significant association between rs7669 and PD risk (P=0.01).
Conclusions:
- The findings support the involvement of the MTIF3 gene in the etiology of Parkinson's disease.
- The rs7669 polymorphism may represent a risk factor for developing sporadic PD.
- Further research into MTIF3's role in mitochondrial function and PD is warranted.
Related Concept Videos
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...